Eydenzelt will be available in both pre-filled syringe and vial formats, and it is approved for all the same uses as the original Eylea treatment.
Surgiphor is formulated as a pre-mixed, sterile irrigation solution designed to help clear surgical wounds of debris and foreign materials during procedures, eliminating the need for hospital staff to prepare the solution on-site.
LumiGuide enables physicians to visualize and guide devices inside the body using light instead of continuous X-ray imaging.
Each year in the United States, more than 20 million abdomen-pelvis CT scans are performed, and the volume continues to increase.
Philips has pioneered helium-free MRI technology, installing over 2,000 of its 1.5T BlueSeal MRI systems globally and conserving more than 6 million liters of liquid helium.
Optiq AI is integrated across three new imaging platforms: Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision.
Measles cases have increased globally, with an estimated 11 million infections in 2024—about 800,000 more than pre-pandemic levels in 2019.
Mjn-neuro’s wearable sensor uses artificial intelligence (AI) to analyze electrical brain signals and predict when a seizure will occur.
WT-7695, a preclinical radiopharmaceutical targeting carbonic anhydrase IX (CA9), was developed in collaboration with the University of Wisconsin-Madison, and SK now holds exclusive worldwide rights to develop, manufacture, and market the drug.
The partnership combines Philips’ next-generation MR technology with Cortechs.ai’s AI-driven quantitative neuroimaging software to transform how doctors detect, monitor, and manage neurological diseases.